Immunoadhesins containing pre-S domains of hepatitis B virus large envelope protein are secreted and inhibit virus infection

Journal of Virology

Volumn 81, Issue 10, 2007, Pages 4912-4918

  Chai, Ning ^a   Gudima, Severin ^a   Chang, Jinhong ^a   Taylor, John ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; ENVELOPE PROTEIN; IMMUNOGLOBULIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; EMBRYO; GENE EXPRESSION; GENETIC TRANSFECTION; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SEROTYPE; VIRUS INFECTION;

ANTIVIRAL AGENTS; CELL LINE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOLOGIC FACTORS; PROTEIN PRECURSORS; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS;

HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 34248345071     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02865-06     Document Type: Article

References (43)

1. Barrera, A., B. Guerra, L. Notvall, and R. E. Lanford. 2005. Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition. J. Virol. 79:9786-9798.
2. Beatrix, B., H. Sakai, and M. Wiedmann. 2000. The alpha and beta subunit of the nascent polypeptide-associated complex have distinct functions. J. Biol. Chem. 275:37838-37845.
3. Bruss, V., and D. Ganem. 1991. The role of envelope proteins in hepatitis B virus assembly. Proc. Natl. Acad. Sci. USA 88:1059-1063.
4. Bruss, V., J. Hagelstein, E. Gerhardt, and P. R. Galle. 1996. Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity. Virology 218:396-399.
5. Bruss, V., X. Lu, R. Thomssen, and W. H. Gerlich. 1994. Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J. 13:2273-2279.
6. Bruss, V., and K. Vieluf. 1995. Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis. J. Virol. 69:6652-6657.
7. Chai, N., and P. Bates. 2006. Na+/H+ exchanger type 1 is a receptor for pathogenic subgroup J avian leukosis virus. Proc. Natl. Acad. Sci. USA 103:5531-5536.
8. Chamow, S. M., and A. Ashkenazi. 1996. Immunoadhesins: principles and applications. Trends Biotechnol. 14:52-60.
9. Chang, J., S. O. Gudima, C. Tarn, X. Nie, and J. M. Taylor. 2005. Development of a novel system to study hepatitis delta virus genome replication. J. Virol. 79:8182-8188.
10. Cheng, C., K. Smith, and B. Moss. 1986. Hepatitis B large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus. J. Virol. 60:337-344.
11. Cho, D. Y., G. H. Yang, C. J. Ryu, and H. J. Hong. 2003. Molecular chaperone GRP78/BiP interacts with the large surface protein of hepatitis B virus in vitro and in vivo. J. Virol. 77:2784-2788.
12. Denny, P. W., S. Gokool, D. G. Russell, M. C. Field, and D. F. Smith. 2000. Acylation-dependent protein export in Leishmania. J. Biol. Chem. 275:11017-11025.
13. Eble, B. E., V. R. Lingappa, and D. Ganem. 1990. The N-terminal (pre-S2) domain of a hepatitis B virus surface glycoprotein is translocated across membranes by downstream signal sequences. J. Virol. 64:1414-1419.
14. Engelke, M., K. Mills, S. Seitz, P. Simon, P. Gripon, M. Schnolzer, and S. Urban. 2006. Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology 43:750-760.
15. Gerlich, W. H., and M. Kann. 2005. Hepatitis B, p. 1226-1268. In B. W. J. Mahy and V. ter Meulen (ed.), Topley and Wilson's microbiology and microbial infections, vol. 2. ASM Press, Washington, DC.
16. Grimm, D., K. Pandey, H. Nakai, T. A. Storm, and M. A. Kay. 2006. Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype. J. Virol. 80:426-439.
17. Gripon, P., I. Cannie, and S. Urban. 2005. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J. Virol. 79:1613-1622.
18. Gripon, P., J. Le Seyec, S. Rumin, and C. Guguen-Guillouzo. 1995. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 213:292-299.
19. Gripon, P., S. Rumin, S. Urban, J. Le Seyec, D. Glaise, I. Cannie, C. Guyomard, J. Lucas, C. Trepo, and C. Guguen-Guillouzo. 2002. Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl. Acad. Sci. USA 99:15655-15660.
20. Gudima, S., Y. He, A. Meier, J. Chang, R. Chen, M. Jarnik, E. Nicolas, V. Bruss, and J. Taylor. 2007. Assembly of hepatitis delta virus: particle characterization including ability to infect primary human hepatocytes. J. Virol. 81:3608-3617.
21. Heermann, K. H., F. Kruse, M. Seifer, and W. H. Gerlich. 1987. Immunogenicity of the gene S and Pre-S domains in hepatitis B virions and HBsAg filaments. Intervirology 28:14-25.
22. Kalies, K. U., and E. Hartmann. 1998. Protein translocation into the endoplasmic reticulum (ER)-two similar routes with different modes. Eur. J. Biochem. 254:1-5.
23. Kuroki, K., R. Russnak, and D. Ganem. 1989. Novel N-terminal amino acid sequence required for retention of a hepatitis B virus glycoprotein in the endoplasmic reticulum. Mol. Cell. Biol. 9:4459-4466.
24. Lambert, C., and R. Prange. 2003. Chaperone action in the posttranslational topological reorientation of the hepatitis B virus large envelope protein: implications for translocational regulation. Proc. Natl. Acad. Sci. USA 100:5199-5204.
25. Lambert, C., and R. Prange. 2001. Dual topology of the hepatitis B virus large envelope protein: determinants influencing post-translational pre-S translocation. J. Biol. Chem. 276:22265-22272.
26. Levine, B. L., L. M. Humeau, J. Boyer, R. R. Macgregor, T. Rebello, X. Lu, G. K. Binder, V. Slepushkin, F. Lemiale, J. R. Mascola, F. D. Bushman, B. Dropulic, and C. H. June. 2006. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc. Natl. Acad. Sci. USA 103:17373-17377.
27. Li, D., X. Z. Wang, J. Ding, and J.-P. Yu. 2005. NACA as a potential cellular target of hepatitis B virus preS1 protein. Dig. Dis. Sci. 50:1156-1160.
28. Loffler-Mary, H., M. Werr, and R. Prange. 1997. Sequence-specific repression of cotranslational translocation of the hepatitis B virus envelope proteins coincides with binding of heat shock protein Hsc70. Virology 235:144-152.
29. Neurath, A. R., S. B. H. Kent, N. Strick, and K. Parker. 1986. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46:429-436.
30. Nickel, W. 2003. The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur. J. Biochem. 270:2109-2119.
31. Nickel, W. 2005. Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic 6:607-614.
32. Ostapchuk, P., P. Hearing, and D. Ganem. 1994. A dramatic shift in the transmembrane topology of a viral envelope glycoprotein accompanies hepatitis B viral morphogenesis. EMBO J. 13:1048-1057.
33. Persing, D. H., H. E. Varmus, and D. Ganem. 1986. Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. Science 234:1388-1391.
34. Persing, D. H., H. E. Varmus, and D. Ganem. 1987. The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid. J. Virol. 61:1672-1677.
35. Prange, R., and R. E. Streeck. 1995. Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO J. 14:247-256.
36. Revill, P., and S. Locarnini. 2006. The clinical virology of hepatitis B. Future Virol. 1:349-360.
37. Ryu, C. J., D. Y. Cho, P. Gripon, H. S. Kim, C. Guguen-Guillouzo, and H. J. Hong. 2000. An 80-kilodalton protein that binds to the pre-S1 domain of hepatitis B virus. J. Virol. 74:110-116.
38. Schreibman, I. R., and E. R. Schiff. 2006. Entacivir: a new treatment for chronic hepatitis B infection. Future Virol. 1:541-552.
39. Sominskaya, I., V. Bichko, P. Pushko, A. Dreimane, D. Snikere, and P. Pumpens. 1992. Tetrapeptide QDPR is a minimal immunodomonant epitope within the preS2 domain of hepatitis B virus. Immunol. Lett. 33:169-172.
40. Sureau, C., C. Fournier-Wirth, and P. Maurel. 2003. Role of N glycosylation of hepatitis B virus envelope proteins in morphogenesis and infectivity of hepatitis delta virus. J. Virol. 77:5519-5523.
41. Ward, R. H., D. J. Capon, C. M. Jett, K. K. Murthy, J. Mordenti, C. Lucas, S. W. Frie, A. M. Prince, J. D. Green, and J. W. Eichberg. 1991. Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin. Nature 352:434-436.
42. Werr, M., and R. Prange. 1998. Role for calnexin and N-linked glycosylation in the assembly and secretion of hepatitis B virus middle envelope protein particles. J. Virol. 72:778-782.
43. Xu, Z., V. Bruss, and T. S. Yen. 1997. Formation of intracellular particles by hepatitis B virus large surface protein. J. Virol. 71:5487-5494.